CENGILD Stock Overview
An investment holding company, operates a medical center in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Cengild Medical Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.27 |
| 52 Week High | RM 0.35 |
| 52 Week Low | RM 0.24 |
| Beta | -0.0050 |
| 11 Month Change | 3.85% |
| 3 Month Change | -3.57% |
| 1 Year Change | -16.92% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.94% |
Recent News & Updates
Recent updates
Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jun 04
Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger
Apr 05Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality
Sep 01A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)
Aug 31Shareholder Returns
| CENGILD | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 8.0% | 1.3% | -0.2% |
| 1Y | -16.9% | 25.7% | 9.7% |
Return vs Industry: CENGILD underperformed the MY Healthcare industry which returned 25.7% over the past year.
Return vs Market: CENGILD underperformed the MY Market which returned 9.7% over the past year.
Price Volatility
| CENGILD volatility | |
|---|---|
| CENGILD Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in MY Market | 10.1% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: CENGILD has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: CENGILD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 159 | Wai Lee | cengild.com |
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, endocrinology, general surgery, internal medicine, orthopedic, plastic and reconstructive surgery, radiology, rheumatology, and thoracic surgery; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy. It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; radiology and imaging services; dietetics and nutrition, physiotherapy, and medical record services; accident and emergency care, and health screenings; and consultant services.
Cengild Medical Berhad Fundamentals Summary
| CENGILD fundamental statistics | |
|---|---|
| Market cap | RM 224.89m |
| Earnings (TTM) | RM 11.08m |
| Revenue (TTM) | RM 66.85m |
20.3x
P/E Ratio3.4x
P/S RatioIs CENGILD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CENGILD income statement (TTM) | |
|---|---|
| Revenue | RM 66.85m |
| Cost of Revenue | RM 35.76m |
| Gross Profit | RM 31.09m |
| Other Expenses | RM 20.01m |
| Earnings | RM 11.08m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.013 |
| Gross Margin | 46.51% |
| Net Profit Margin | 16.57% |
| Debt/Equity Ratio | 0% |
How did CENGILD perform over the long term?
See historical performance and comparison